News - TransCelerate BioPharma, Abbott Laboratories

Filter

Popular Filters

1 to 25 of 78 results

New Zealand to fully subsidize Abbott Lab’s Ferrograd

New Zealand to fully subsidize Abbott Lab’s Ferrograd

06-01-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has approved an agreement with the local subsidiary…

Abbott LaboratoriesAsia-PacificFerrogradFinancialHematologyPharmaceutical

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

28-11-2013

In further legal action against drugmakers allegedly over pricing AIDS drugs in the USA, the AIDS Healthcare…

Abbott LaboratoriesAbbVieAnti-viralsKaletra TabletsLegalNorth AmericaNorvirPharmaceuticalPricing

Abbott Labs beats forecasts, despite China woes

Abbott Labs beats forecasts, despite China woes

16-10-2013

Abbott Laboratories, which last year spun off its research-based prescription medicines into AbbVie,…

Abbott LaboratoriesFinancialPharmaceutical

Agreements for influenza vaccine approved in New Zealand

15-10-2013

New Zealand’s PHARMAC has reached agreements with subsidiaries of GlaxoSmithKline and Abbott Laboratories…

Abbott LaboratoriesFluarixGlaxoSmithKlineHealthcareInfluvacNew ZealandPharmaceuticalPricingVaccines

New Zealand proposals for influenza vaccines

21-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

US FDA warns pregnant women to not use valproate migraine prevention medicines

07-05-2013

The US Food and Drug Administration is alerting health care providers and patients that medications including…

Abbott LaboratoriesGenericsNeurologicalNorth AmericaNoven PharmaceuticalsPharmaceuticalRegulationSanofivalproate Sodium Injection

Leading Russian vaccines producer Petrovax acquired by Pharmstandard

07-05-2013

Russian drugmaker Pharmstandard is to acquire Petrovax Pharm, one of the country's largest producers…

Abbott LaboratoriesMergers & AcquisitionsPetrovax FarmPharmaceuticalPharmstandardVaccines

Abbott Labs told it cannot acquire Russia's Petrovax Farm

22-04-2013

The Russian government has imposed a ban on the sale of Petrovax Farm, one of Russia's leading vaccines…

Abbott LaboratoriesBiotechnologyMergers & AcquisitionsPetrovax FarmVaccines

Positive Ph III results for AbbVie's Humira in pediatric Crohn's disease; five leukemia studies suspended

17-02-2013

AbbVie (NYSE: ABBV), the new spin-out from Abbott Laboratories, has announced the first long-term, patient-reported…

Abbott LaboratoriesAbbVieAnti-Arthritics/RheumaticsGastro-intestinalsHumiraOncologyPharmaceuticalResearch

AbbVie inaugural full-year outlook for 2013 in line with expectations

31-01-2013

Newly spun-out from Abbott Labs, research-based pharma company AbbVie (NYSE: ABB) yesterday confirmed…

Abbott LaboratoriesAbbVieFinancialPharmaceuticalResearch

Abbott Labs 4th-qtr net income plunges

23-01-2013

US health care major Abbott Laboratories (NYSE: ABT) posted sales of $10.84 billion for the fourth quarter…

Abbott LaboratoriesFinancialPharmaceutical

Abbott board prepares way for AbbVie split off

29-11-2012

US health care giant Abbott Laboratories (NYSE: ABT) says that its board of directors has approved the…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

Biosimilars threaten to burst Humira's blockbuster bubble

29-11-2012

US health care major Abbott Laboratories' (NYSE: ABT) Humira (adalimumab) has a strong reputation as…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGenericsHumiraMarkets & Marketing

EU Commission approves Bayer's Eylea for wet AMD and Abbott's Humira for pediatric Crohn's

28-11-2012

There was good news yesterday for Germany's Bayer (BAYN: DE) and US health care major Abbott Laboratories…

Abbott LaboratoriesBayerEuropeEyleaGastro-intestinalsHumiraOphthalmicsPharmaceuticalRegeneronRegulation

Abbott launches Sucampo's Amitiza in Japan

27-11-2012

US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP), and marketing partner health care major Abbott Laboratories…

Abbott LaboratoriesAmitizaAsia-PacificGastro-intestinalsMarkets & MarketingPharmaceuticalSucampo

Janssen starts new trial investigator databank, joined by Merck & Co and Lilly

15-11-2012

Janssen Research & Development, a unit of health care giant Johnson & Johnson (NYSE: JNJ) yesterday announced…

BiotechnologyPharmaceuticalResearchTransCelerate BioPharma

Abbott presents new Humira data at ACR

12-11-2012

US pharma major Abbott Laboratories (NYSE: ABT) today announced results from a post-hoc analysis of its…

Abbott LaboratoriesAnti-Arthritics/RheumaticsHumiraPharmaceuticalResearch

Abbott Labs' AbbVie bond deal hit $37 billion yesterday, sources report

06-11-2012

US health care major Abbott Laboratories (NYSE: ABT) and its subsidiary AbbVie came to market early Monday…

Abbott LaboratoriesAbbVieFinancialPharmaceutical

AET BioTech and BioXpress to co-develop biosimilar Humira

02-11-2012

Plans to develop another biosimilar version of Abbott Laboratories blockbuster rheumatoid arthritis drug…

Abbott LaboratoriesadalimumabAET BioTechAnti-Arthritics/RheumaticsBiotechnologyBioXpress TherapeuticsGenericsHumiraProductionResearch

Seattle Genetics and Abbott expand ADC collaboration

24-10-2012

Seattle Genetics and Abbott expand ADC collaboration

Abbott LaboratoriesBiotechnologyLicensingOncologyPharmaceuticalSeattle Genetics

1 to 25 of 78 results

Back to top